Literature DB >> 12073019

D-loop mutations in mitochondrial DNA: link with mitochondrial DNA depletion?

Cyrille Barthélémy1, Hélène Ogier de Baulny, Anne Lombès.   

Abstract

Clinical presentation of the patients with mitochondrial DNA depletion is quite diverse and is suggestive of genetic heterogeneity. Autosomal recessive inheritance of the disease appears likely, thus implying the nuclear origin of the disease. This has been demonstrated recently in large families with neonatal presentation of the disease. Here, we report upon a family with one child having a late-onset disease associated with severe mitochondrial DNA depletion. The presence of mitochondrial alterations in the muscle of the patient's mother prompted us to extensively analyse the mitochondrial DNA in the family. We found mitochondrial DNA multiple deletions, but also three heteroplasmic point mutations of the D-loop region, two of which (T119C and T408A) affect conserved regions involved in the mtDNA replication process. These mutations were non-randomly distributed in the maternal lineage and, for one of them, among single muscle fibres. Involvement of the mitochondrial DNA in its own depletion appears therefore possible. It may act in close relationship with a hypothetical modified nuclear factor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12073019     DOI: 10.1007/s00439-002-0708-4

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  7 in total

1.  Roles of Mitochondrial DNA Changes on Cancer Initiation and Progression.

Authors:  Masahiro Higuchi
Journal:  Cell Biol (Henderson, NV)       Date:  2012-10-25

2.  Molecular and clinical genetics of mitochondrial diseases due to POLG mutations.

Authors:  Lee-Jun C Wong; Robert K Naviaux; Nicola Brunetti-Pierri; Qing Zhang; Eric S Schmitt; Cavatina Truong; Margherita Milone; Bruce H Cohen; Beverly Wical; Jaya Ganesh; Alice A Basinger; Barbara K Burton; Kathryn Swoboda; Donald L Gilbert; Adeline Vanderver; Russell P Saneto; Bruno Maranda; Georgianne Arnold; Jose E Abdenur; Paula J Waters; William C Copeland
Journal:  Hum Mutat       Date:  2008-09       Impact factor: 4.878

3.  Consumption of oxygen: a mitochondrial-generated progression signal of advanced cancer.

Authors:  C C Cook; A Kim; S Terao; A Gotoh; M Higuchi
Journal:  Cell Death Dis       Date:  2012-01-19       Impact factor: 8.469

4.  Mutations in mitochondrial DNA polymerase-gamma promote breast tumorigenesis.

Authors:  Keshav K Singh; Vanniarajan Ayyasamy; Kjerstin M Owens; Manika Sapru Koul; Marija Vujcic
Journal:  J Hum Genet       Date:  2009-07-24       Impact factor: 3.172

Review 5.  Engineering Genetic Systems for Treating Mitochondrial Diseases.

Authors:  Yoon-Ha Jang; Sae Ryun Ahn; Ji-Yeon Shim; Kwang-Il Lim
Journal:  Pharmaceutics       Date:  2021-05-28       Impact factor: 6.321

6.  Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations.

Authors:  Neil Ashley; Anthony O'Rourke; Conrad Smith; Susan Adams; Vasantha Gowda; Massimo Zeviani; Garry K Brown; Carl Fratter; Joanna Poulton
Journal:  Hum Mol Genet       Date:  2008-05-16       Impact factor: 6.150

7.  Recurrent tissue-specific mtDNA mutations are common in humans.

Authors:  David C Samuels; Chun Li; Bingshan Li; Zhuo Song; Eric Torstenson; Hayley Boyd Clay; Antonis Rokas; Tricia A Thornton-Wells; Jason H Moore; Tia M Hughes; Robert D Hoffman; Jonathan L Haines; Deborah G Murdock; Douglas P Mortlock; Scott M Williams
Journal:  PLoS Genet       Date:  2013-11-07       Impact factor: 5.917

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.